| Date | Time | Source | Announcement |
|---|---|---|---|
| 07 Feb 2017 | 07:00 AM | Concepta signs agreement with Selective Antibodies | |
| 09 Jan 2017 | 07:00 AM | Concepta achieves ISO13485 accreditation | |
| 08 Dec 2016 | 07:00 AM | Appointment China Country Manager | |
| 08 Nov 2016 | 07:09 AM | New manufacturing facility in Doncaster | |
| 10 Oct 2016 | 03:53 PM | Issue of Equity | |
| 26 Sep 2016 | 07:00 AM | Chinese Manufacturing Agreement Signed | |
| 21 Sep 2016 | 07:00 AM | New Laboratory Opening | |
| 18 Aug 2016 | 07:00 AM | Interim Results | |
| 27 Jul 2016 | 04:11 PM | TR-1: Notification of major interest in shares | |
| 27 Jul 2016 | 02:28 PM | TR-1: Notification of major interest in shares | |
| 27 Jul 2016 | 09:41 AM | TR-1: Notification of major interest in shares | |
| 26 Jul 2016 | 08:00 AM | Admission to AIM |
MyHealthChecked PLC is a United Kingdom-based consumer home-testing healthcare company. The Company is the umbrella brand of a range of at-home rapid tests, as well as deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and blood sample collection kits. The Company also provides COVID tests. The Company's multi-platform portfolio of tests offers users access to a variety of test types, sample collection options, and levels of analysis, enabling it to meet diverse customer needs.
The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analyzed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase.
MyHealthChecked is listed in London under the ticker MHC.
MHC share price launched at 26,000p in 2013.